Trial intelligence / Profile preview

Effect of two surfactant administration methods on preterm neonates with respiratory distress syndrome

IRCT20220401054389N1Phase 3Completed

Sponsor
Mashhad University of Medical Sciences
Start
Apr 2022
Countries
1
01

Overview

Phase 3 trial of bovactant in respiratory distress syndrome (RDS) (2 arms), sponsored by Mashhad University of Medical Sciences. Started Apr 2022; status: completed.

02

Drugs

bovactant
03

Conditions

respiratory distress syndrome (RDS)

Beyond the preview

Go deeper on IRCT20220401054389N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20220401054389N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call